Klotz, Luisa http://orcid.org/0000-0001-5439-9633
Antel, Jack
Kuhlmann, Tanja http://orcid.org/0000-0002-0174-5042
Article History
Accepted: 15 March 2023
First Online: 14 April 2023
Competing interests
: L.K. received compensation for serving on Scientific Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Genzyme, Horizon, Janssen, Merck Serono, Novartis, Roche and Viatris. She received speaker honoraria and travel support from Bayer, Biogen, Bristol-Myers Squibb, Genzyme, Grifols, Merck Serono, Novartis, Roche, Santhera and Teva. She receives research support from the German Research Foundation, the Interdisciplinary Center for Clinical Research (IZKF) Münster, IMF Münster, Biogen, Immunic AG, Novartis and Merck Serono. J.A. has no competing interests. T.K. received research funding from the German Research Foundation, IZKF Münster, National MS Society, Progressive MS Alliance, European Commission (H2020-MSCA-ITN-2018) and Novartis. She received compensation for serving on scientific advisory boards (Novartis) and speaker honoraria from Biogen, Novartis and Roche.